Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Price Passes Above 200-Day Moving Average of $0.00

Share on StockTwits

Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $13.66. Global X Genomics & Biotechnology ETF shares last traded at $13.61, with a volume of 4,671 shares.

The business has a 50 day simple moving average of $13.99.

A hedge fund recently bought a new stake in Global X Genomics & Biotechnology ETF stock. Jane Street Group LLC purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,217 shares of the company’s stock, valued at approximately $381,000. Jane Street Group LLC owned approximately 7.20% of Global X Genomics & Biotechnology ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.

Further Reading: Purposes and Functions of the Federal Reserve

Receive News & Ratings for Global X Genomics & Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.